Display options
Share it on

Front Psychol. 2015 Jun 02;6:656. doi: 10.3389/fpsyg.2015.00656. eCollection 2015.

A quantitative epigenetic approach for the assessment of cigarette consumption.

Frontiers in psychology

Robert Philibert, Nancy Hollenbeck, Eleanor Andersen, Terry Osborn, Meg Gerrard, Frederick X Gibbons, Kai Wang

Affiliations

  1. Department of Psychiatry, University of Iowa, Iowa City, IA USA ; Behavioral Diagnostics, Iowa City, IA USA.
  2. Department of Psychiatry, University of Iowa, Iowa City, IA USA.
  3. Behavioral Diagnostics, Iowa City, IA USA.
  4. Department of Psychology-Center for Health Intervention and Prevention, University of Connecticut, Storrs, CT USA.
  5. Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA USA.

PMID: 26082730 PMCID: PMC4451580 DOI: 10.3389/fpsyg.2015.00656

Abstract

Smoking is the largest preventable cause of morbidity and mortality in the world. Despite the development of numerous preventive and treatment interventions, the rate of daily smoking in the United States is still approximately 22%. Effective psychosocial interventions and pharmacologic agents exist for the prevention and treatment of smoking. Unfortunately, both approaches are hindered by our inability to accurately quantify amount of cigarette consumption from the point of initial experimentation to the point of total dependency. Recently, we and others have demonstrated that smoking is associated with genome-wide changes in DNA methylation. However, whether this advance in basic science can be employed as a reliable assay that is useful for clinical diagnosis and treatment has not been shown. In this communication, we determine the sensitivity and specificity of five of the most consistently replicated CpG loci with respect to smoking status using data from a publically available dataset. We show that methylation status at a CpG locus in the aryl hydrocarbon receptor repressor, cg05575921, is both sensitive and specific for smoking status in adults with a receiver operated curve characteristic area under the curve of 0.99. Given recent demonstrations that methylation at this locus reflects both intensity of smoking and the degree of smoking cessation, we conclude that a methylation-based diagnostic at this locus could have a prominent role in understanding the impact of new products, such as e-cigarettes on initiation of cigarette smoking among adolescents, while improving the prevention and treatment of smoking, and smoking related disorders.

Keywords: DNA methylation; aryl hydrocarbon receptor repressor; cg05575921; diagnostics; e-cigarettes; epigenetics; smoking

References

  1. Hum Mol Genet. 2013 Mar 1;22(5):843-51 - PubMed
  2. Am J Med Genet B Neuropsychiatr Genet. 2008 Jul 5;147B(5):565-70 - PubMed
  3. Ann Med. 2012 Sep;44(6):588-97 - PubMed
  4. J Adolesc Health. 2013 Feb;52(2):144-50 - PubMed
  5. Environ Sci Technol. 2005 Jan 15;39(2):471-8 - PubMed
  6. BMC Genomics. 2014 Feb 22;15:151 - PubMed
  7. Addict Behav. 2005 Jan;30(1):175-81 - PubMed
  8. J Intern Med. 2001 Feb;249(2):145-51 - PubMed
  9. Environ Health Perspect. 2014 Jul;122(7):673-8 - PubMed
  10. PLoS One. 2013 May 17;8(5):e63812 - PubMed
  11. Nicotine Tob Res. 2009 Jan;11(1):12-24 - PubMed
  12. Clin Epigenetics. 2013 Oct 11;5(1):19 - PubMed
  13. Clin Epigenetics. 2014 Feb 03;6(1):4 - PubMed
  14. Int J Hyg Environ Health. 2014 Jul;217(6):628-37 - PubMed
  15. Am J Epidemiol. 2011 Feb 1;173(3):355-9 - PubMed
  16. J Stud Alcohol. 1994 Mar;55(2):149-58 - PubMed
  17. Environ Sci Technol. 2008 Sep 1;42(17):6385-91 - PubMed
  18. Addiction. 2008 Sep;103(9):1553-61 - PubMed
  19. MMWR Morb Mortal Wkly Rep. 2011 Sep 9;60(35):1207-12 - PubMed
  20. Drug Alcohol Depend. 2008 Dec 1;98(3):203-9 - PubMed
  21. Environ Health Perspect. 2012 Oct;120(10):1425-31 - PubMed
  22. Epigenetics. 2014 Sep;9(9):1212-9 - PubMed
  23. BMJ. 2009 Oct 29;339:b4347 - PubMed
  24. Mol Diagn Ther. 2014 Apr;18(2):127-35 - PubMed
  25. Nicotine Tob Res. 2007 Aug;9(8):845-52 - PubMed
  26. Epigenetics. 2014 Oct;9(10):1382-96 - PubMed
  27. Am J Med Genet B Neuropsychiatr Genet. 2015 Jan;168B(1):36-44 - PubMed
  28. Am J Med Genet B Neuropsychiatr Genet. 2012 Mar;159B(2):141-51 - PubMed
  29. MMWR Morb Mortal Wkly Rep. 2008 Nov 14;57(45):1226-8 - PubMed
  30. Med J Aust. 2004 Apr 5;180(7):317-8 - PubMed
  31. Epigenetics. 2012 Nov;7(11):1331-8 - PubMed
  32. Eur Heart J. 2012 Nov;33(22):2841-8 - PubMed
  33. PLoS One. 2009 Nov 23;4(11):e7959 - PubMed
  34. MMWR Morb Mortal Wkly Rep. 2013 Sep 6;62(35):729-30 - PubMed
  35. Hum Mol Genet. 2015 Apr 15;24(8):2349-59 - PubMed
  36. Inhal Toxicol. 2012 Oct;24(12 ):850-7 - PubMed
  37. Am J Respir Crit Care Med. 2009 Sep 1;180(5):462-7 - PubMed
  38. Clin Epigenetics. 2014 Nov 19;6(1):28 - PubMed
  39. Int J Epidemiol. 2014 Aug;43(4):1215-25 - PubMed
  40. Hum Mol Genet. 2014 May 1;23(9):2290-7 - PubMed
  41. Circulation. 2014 May 13;129(19):1972-86 - PubMed
  42. Ther Drug Monit. 2009 Feb;31(1):14-30 - PubMed
  43. Expert Rev Mol Diagn. 2014 Apr;14(3):293-305 - PubMed
  44. Pediatrics. 2015 Jan;135(1):e43-51 - PubMed

Publication Types

Grant support